NCT05516316View on ClinicalTrials.gov

Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions
Chronic Obstructive Pulmonary DiseaseCOPD
Interventions
DRUG

EP395

Capsule for oral use

DRUG

Placebo

Capsule for oral use

Trial Locations (1)

30625

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hanover

Sponsors
All Listed Sponsors
collaborator

FGK Clinical Research GmbH

INDUSTRY

lead

EpiEndo Pharmaceuticals

INDUSTRY